Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring

CAMBRIDGE, Mass., May 10, 2022 /PRNewswire/ -- The U.S. Centers for Disease Control (CDC) has selected Biobot Analytics to expand the agency's National Wastewater Surveillance System (NWSS), an integral part of President Biden's plan to fight Covid-19 and prepare the country for future pandemics....

2022-05-10 00:00 3834

Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report

DURHAM, N.C. and BEIJING, May 7, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company," stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health...

2022-05-07 09:00 6648

SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER

Authorities can rely on a robust decision-making tool to strengthen their fight against the COVID-19 pandemic and future health risks. LAUSANNE, Switzerland, May 6, 2022 /PRNewswire/ -- The Swiss company SICPA, a world leader in identification, traceability and authentication technologies, and t...

2022-05-06 14:00 6006

SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER

Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama

FREDERICK, Md., April 29, 2022 /PRNewswire/ -- Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio's protease inhibitors and ...

2022-04-29 01:00 2899

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV ...

2022-04-27 00:09 3880

The First International COVID-19 Testing Standard Released

BEIJING, April 26, 2022 /PRNewswire/ -- According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO i...

2022-04-26 13:02 1797

Confusing health requirements are stopping passengers from flying

An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis * Many people in every country surveyed sa...

2022-04-22 02:45 6249

Confusing health requirements are stopping passengers from flying

Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine

* Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic * Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 * Immune response confirmed in st...

2022-04-21 02:36 4371

Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan

* Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older inJapan * Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination GAITHERSBURG, Md., April 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a bi...

2022-04-19 19:15 4220

Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

* New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress * Several abstracts and presentations slated to highlight updates on NVX-CoV2373, Novavax' COVID-19 vaccine GAITHERSBURG, Md., April 18, 2022 /PRNewswire/ -- Novavax...

2022-04-18 22:13 4782

WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19

BEIJING, April 18, 2022 /PRNewswire/ -- A news report by haiwainet.cn: On March 31, World Health Organization released the meeting report of "WHO Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in the Treatment of COVID-19" on its official website. The report acknowledged that ...

2022-04-18 15:18 2593

Initiating a Globally-Recognized Vaccine Passport, Indonesia's G20 HWG Meeting Series Welcome More International Visitors

JAKARTA, Indonesia, April 13, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series, organized by The Indonesian Ministry of Health, took place on 28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's G20 preside...

2022-04-13 17:27 2199

Receipt Of Approval From The UAE For Phase II/III Clinical Trial Of Sequential Booster Vaccination For ReCOV

TAIZHOU, China, April 13, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Company", together with its subsidiaries, the "Group",Stock code:2179.HK) is pleased to announce that the Company has received approval from the Ministry of Health and Prevention of theUnited Arab Emirates ("U...

2022-04-13 12:56 4663

HIGH-TECH DROIDS UNITE AT DORSETT WANCHAI

To Ensure Guests a Safe & Healthy Quarantine Stay From HKD990nett per night with Daily 3 Meals & USD24-110 Cash Credits HONG KONG, April 13, 2022 /PRNewswire/ -- The award-winning Dorsett Wanchai, Hong Kong c...

2022-04-13 12:24 4621

HIGH-TECH DROIDS UNITE AT DORSETT WANCHAI

Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou

TAIZHOU, China, April 11, 2022 /PRNewswire/ -- The board of directors of Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group",Stock code:2179.HK) is pleased to announce that, on April 9, 2022, the Company has received the European Union (EU) Qualified Pe...

2022-04-11 16:05 3204

Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand

GAITHERSBURG, Md., and PUNE, India, April 8, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine ...

2022-04-08 21:00 5851

Tianlong COVID-19 Solution Safeguards Passengers In Jakarta International Airport In Indonesia

XI'AN, China, April 8, 2022 /PRNewswire/ -- Tianlong's integrated PCR lab solution is installed inJakarta's international airport in Indonesia to help conduct nucleic acid testing for inbound and outbound passengers. Since its installation inSeptember 2021, Tianlong's COVID-19 solution has helped...

2022-04-08 15:04 3944

Tianlong COVID-19 Solution Safeguards Passengers In Jakarta International Airport In Indonesia

New very-high-sensitivity rapid antigen test kits hit Australian market

New COVID-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available inAustralia MELBOURNE, Australia, April 8, 2022 /PRNewswire/ -- Medriva; https://medriva.com , a leading global manufacturer of COVID-19 testing and vaccination products, announced the Aus...

2022-04-08 06:00 3714

New very-high-sensitivity rapid antigen test kits hit Australian market

Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business

China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for Everest's mRNA technology platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancement of Everest's po...

2022-04-07 07:30 5075

Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative

MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...

2022-04-06 19:37 3982

1 ... 12 13 141516 17 18 ... 26